HOFSETH BIOCARE ASHOFSETH BIOCARE ASHOFSETH BIOCARE AS

HOFSETH BIOCARE AS

No trades
See on Supercharts

HBC fundamentals

HOFSETH BIOCARE AS financial statements, including revenue, expenses, profit, and loss

The total revenue of HBC for the last quarter is 45.89 M NOK, and it's 7.53% lower compared to the previous quarter. The net income of Q4 23 is -51.89 M NOK.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: NOK
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth